TrialMedicine2017
Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease.
Yuhong Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it